Exemestane Reports: US Guidelines Urge Breast Cancer Screening From Age 50

Exemestane Reports: US Guidelines Urge Breast Cancer Screening From Age 50

Edit: Shenzhen OK Biotech Technology Co., Ltd.    Date: 2016-01-12

Exemestane reports: US guidelines urge breast cancer screening from age 50
MIAMI - Women 50 and older should get a mammogram to screen for breast cancer every two years, while women in their 40s should decide with their doctors, said US guidelines Monday.

The newest recommendations by the US Preventive Services Task Force stoked new controversy over what is best for women, who not long ago were urged to get a mammogram every year starting at age 40. The guidelines are based on findings from six independent research teams, which crafted "simulation models to analyze 10 different digital breast cancer screening strategies for the average-risk US female population," said a description of the work in the Annals of Internal Medicine.

The new guidance accounts for the latest scientific data on the potential harms -- such as over-diagnosis, false-positives and benign biopsies -- of screening using digital mammography. It also takes into account knowledge about molecular subtypes of cancer as well as how breast density plays into risk.

"Mammography screening every two years for average-risk women ages 50 to 74 offers a favorable balance of benefits to harm," said the guidelines.

Dear Ms./Mr.,
Good day. 

(Quality is our culture)

Alen Gao from Shenzhen OK Biotech Technology Co,.Ltd., China, professional for pharmaceutical intermediates,Steroid Hormone Powders or Chemical raw materials. Such as Flibanserin, Testosterone , Mesterolone, Tadalafil, Boldenone,  Trenbolone,  Methyltesterone, Tamoxifen Citrate,Clomiphene citrate,etc..
We have our own factary, the price will  be very  competitive. We also can ship to worldwide with safe package. With us your money is safe and your business in safe .

Hope to hear from you soon.
Emailalen@ok-biotech.com 
Skype: alen@ok-biotech.com
Mobile: +86 852 64872529
Www.ok-biotech.com

评论

此博客中的热门博文

Post Cycle Therapy

Masteron (drostanolone propionate)

Chapter 1.Why do the clients choose our company?